ClinicalThought

Share

Program Content

Activities

  • Atezo + Bev in Adv HCC
    A New Regimen for Advanced HCC: Atezolizumab Plus Bevacizumab
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 15, 2020

    Expires: September 14, 2021

  • Transitioning Therapy
    Key Concepts in HCC Treatment: Transitioning Patients From Locoregional to Systemic Therapy
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 20, 2020

    Expires: October 19, 2021

  • HCC With Child-Pugh B
    How I Select Systemic Therapy for Patients With Advanced HCC and Child-Pugh B Cirrhosis
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 18, 2020

    Expires: November 17, 2021

Faculty

cover img faculity

Mark Yarchoan, MD

Assistant Professor
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins
Baltimore, Maryland

cover img faculity

Richard S. Finn, MD

Assistant Professor of Medicine
Division of Hematology-Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

ProCE Banner

Supporters

Eisai

Exelixis, Inc.

Genentech, a member of the Roche Group

Lilly

Merck Sharp & Dohme Corp.